|
|
Volumn 7, Issue 3, 2006, Pages 197-
|
|
Oral regimen for metastatic neuroendocrine tumours.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DACARBAZINE;
DRUG DERIVATIVE;
TEMOZOLOMIDE;
THALIDOMIDE;
ARTICLE;
CLINICAL TRIAL;
HUMAN;
NEUROENDOCRINE TUMOR;
ORAL DRUG ADMINISTRATION;
PATHOLOGY;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
DACARBAZINE;
HUMANS;
NEUROENDOCRINE TUMORS;
THALIDOMIDE;
TREATMENT OUTCOME;
|
|
EID: 33645219520
PISSN: 14702045
EISSN: None
Source Type: Journal
DOI: 10.1016/S1470-2045(06)70594-0 Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
